An Analysis of Worlwide Prescription and OTC Sales by Technology (2002 - 2012)
By Mark P. Mathieu
EvaluatePharma calculates that worldwide pharmaceutical sales from biotechnology products increased 20%, to $94bn, in 2007.
Read More
|
|
Genetic Hints for Schizophrenia
Jul 02
|
BBC News | The largest ever study of schizophrenia has revealed a collection of genetic variants which could together account for more than a third of the inherited risk of schizophrenia.
more
Gene Mapping Test for Embryos 'Very Near'
Jul 01
|
BBC News | U.K. researchers are saying that a genetic mapping technique called karyomapping will enable doctors to tell if an embryo is in "generally good genetic shape," and will be available within the year.
more
MORE NEWS BELOW
The League of Extraordinary Stem Cell Biologists
Jun 30
|
Boston Magazine | What it's like to be three scientists from the Harvard Stem Cell Institute: young, brilliant, fawned over by multimillionaire investors, courted by universities and corporations around the world, and forever racing—sometimes as teammates, sometimes as rivals—to change medicine as we know it.
more
Genentech CFO Hired by Facebook
Jun 30
|
Business Week | David Ebersman, a 15 year veteran of Genentech, has been named the new Chief Financial Officer of Facebook, the social networking site.
more
VCs Should Look into Bundling Biotech
Jun 29
|
Wall Street Journal | Venture firms should bundle their biotech portfolios, says NovaQuest president Ron Wooten, to make them more attractive to investors. He reasons that betting on a small biotech's single product isn't as smart as a promising group of start-ups in a single portfolio.
more
 | Biomarkers: An Indispensible Addition to the Drug Development Toolkit Examining the Potential of Biomarkers Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents. Discover the potential of biomarkers to: - Improve decision making
- Accelerate drug development
- Reduce development costs
|  | Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses: - The information technology challenges of gene sequencing
- “Intelligent” methods for data management and customization
- System survival tips... Deciding what data to keep or delete
- New tools to keep scientists ahead of impending data torrents
|  | Managed Innovation, Assured Compliance Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.
|
Presented by Trade Commission of Spain
Spain Biotech: An Engine for Economic Change
 Discover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.
Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.
Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.
Access the podcast
 |
Innovative management in clinical trials
|
 |
Leaders in quality training resources
|
 |
Reports evaluating issues in pharmaceutical technology, business, and therapeutic markets
|
|
|
Jul 2, 2009
| Bio-IT World |
FULL STORIES
- Illumina and Knome perform sequencing for PBS documentary
- LabVantage buys Applied Bio LIMS
Bio-IT Weekly Update
eCliniqua
Predictive Biomedicine
MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING (Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland. In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required. PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience. View complete job posting & apply: www.saic-frederick.com. Position #146945.
|